Liver cancer is life-threatening because it is generally diagnosed in the later stages. Now, scientists have identified a diagnostic biomarker of the disease and a potential way to reverse the damage done.
"Hepatocellular carcinoma, the most common form of liver cancer, remains the third leading cause of cancer-related deaths worldwide due to a lack of biomarkers for early detection and rapid fatality shortly after diagnosis," said Ying Fu from the Georgetown Lombardi Comprehensive Cancer Centre in Washington, DC.
In new research, Fu and his team found that a damaged lesion on a DNA base (guanine) is correlated with the development of hepatocellular carcinoma in two mouse models.
"It has the potential to serve as a biomarker for early detection of hepatocellular carcinoma," the team noted.
Furthermore, polyphenon E, a formulation of green tea extract containing antioxidant catechins (plant metabolites) showed the most potent effect to suppress the lesion.
"More importantly, 86 percent of the mice on the polyphenon E diet appeared to have complete protection from tumour development," Fu claimed.
The study was presented at the American Association for Cancer Research's (AACR) annual meeting in Philadelphia this week.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
